Changes to the website
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4561

Next 25
Website Changes
01/17/2018 Midatech and UCSF receive IND approval for DIPG treatment MTX110
01/17/2018 Help Us Understand Glioblastoma Multiforme (GBM) Patient Experiences better through a quick survey:
01/17/2018 High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy.
01/17/2018 Long Island resident with recurrent brain cancer receives novel experimental treatment at Lenox Hill Hospital
01/11/2018 Drugs targeting the cells circadian rhythm offers hope for glioblastoma
01/10/2018 Dr. Kurt Jaeckle to Lead Phase III Clinical Trial of Novel Drug VAL-083 for Late-Stage Glioblastoma
01/08/2018 Study Finds Growing Socioeconomic and Racial Disparities in Management of Brain Metastases
01/06/2018 Help Us Understand Glioblastoma Multiforme (GBM) Patient Experiences better through a quick survey:
01/05/2018 Bettye J. Wiley Hooks shares lessons of own battle with cancer
12/29/2017 Musella Foundation awards brain tumor research grant!
12/29/2017 Charitable giving to take a hit from the tax law
12/28/2017 Foundation Aims For Virtual Trial Registry To Help Patients With Brain Cancer Get Drugs Sooner
12/27/2017 Cancer Drug Price Rises 1,400% With No Generic to Challenge It
12/27/2017 Diffusion Pharmaceuticals Begins Phase 3 Clinical Trial with TSC in Glioblastoma Multiforme
12/26/2017 DelMar Pharmaceuticals announces Fast Track designation for VAL-083 in recurrent Glioblastoma
12/23/2017 Musella Foundation Co-pay Assistance Program Status
12/23/2017 Highlights from the Society for Neuro Oncology annual meeting, San Francisco California, November 16-19 2017
12/23/2017 Musella Foundation awards brain tumor research grant!
12/19/2017 JAMA Publishes Final Analysis of EF-14 Phase 3 Pivotal Trial of Optune® Together with Temozolomide Demonstrating Unprecedented Survival Results for Newly Diagnosed Glioblastoma
12/07/2017 Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
12/06/2017 FDA Grants Genentech’s Avastin Full Approval for Most Aggressive Form of Brain Cancer
12/04/2017 A novel immuno-oncology approach to treating a rare childhood brain cancer
12/03/2017 Correction regarding dose of Avastin in an old article
12/03/2017 Tumor response of temozolomide in combination with morphine in a xenograft model of human glioblastoma.
12/02/2017 Promising target for treating brain tumors in children



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites